DDD Partners LLC lessened its holdings in shares of Vicarious Surgical Inc (NYSE:RBOT - Free Report) by 20.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 185,467 shares of the company's stock after selling 46,453 shares during the period. DDD Partners LLC owned 3.14% of Vicarious Surgical worth $2,441,000 as of its most recent SEC filing.
Wall Street Analyst Weigh In
Separately, Piper Sandler dropped their target price on shares of Vicarious Surgical from $12.00 to $10.50 and set a "neutral" rating on the stock in a report on Wednesday, November 13th.
Check Out Our Latest Analysis on RBOT
Vicarious Surgical Stock Performance
Shares of RBOT traded up $0.06 during trading hours on Wednesday, hitting $15.76. The company had a trading volume of 68,859 shares, compared to its average volume of 51,661. The stock has a market capitalization of $93.11 million, a price-to-earnings ratio of -1.54 and a beta of 1.32. The firm has a fifty day moving average price of $13.65 and a 200-day moving average price of $9.95. Vicarious Surgical Inc has a 52-week low of $4.27 and a 52-week high of $19.00.
Vicarious Surgical Company Profile
(
Free Report)
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Read More
Before you consider Vicarious Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vicarious Surgical wasn't on the list.
While Vicarious Surgical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
